Home / Learn

Testosterone for women in menopause: what it can (and can't) do for low libido

The short answer

The only evidence-based reason for women to use testosterone is low sexual desire that causes distress after menopause, following a proper assessment. In trials it led to modest gains, about one extra satisfying sexual event a month. No testosterone product is FDA-approved for women in the US, so it is prescribed off-label, and it has not been shown to help mood, energy, memory or bones.

Your desire has quietly packed its bags, and you miss it. Maybe a friend mentioned testosterone, or you saw a clinic ad promising energy, focus and your old sex drive back. Testosterone for women is having a moment, and there is real evidence behind part of the story. But the hype has run well ahead of the science. Here's what testosterone can do, what it can't, and where things stand in the US as of October 2026.

The short answer

An international consensus statement endorsed by The Menopause Society, the Endocrine Society and other major groups concluded that the only evidence-based use for testosterone in women is treating postmenopausal women with hypoactive sexual desire disorder (HSDD): low desire that causes distress, diagnosed after a full assessment. For that, it helps modestly. For almost everything else it's marketed for, the evidence isn't there.

Where things stand in the US

As Mayo Clinic puts it, testosterone isn't FDA-approved to treat sexual conditions in women. Clinicians who prescribe it do so off-label, using either a compounded product or a product made for men at a female dose. On September 17, 2026, the FDA's Office of Women's Health and its drug center held a public meeting on testosterone use in menopausal women, citing "critical knowledge gaps" on sexual function, cognition, mood and musculoskeletal health. Experts at the meeting confirmed there is still no FDA-approved product for women. We'll update this page if that changes. In the UK, the NHS says testosterone isn't licensed for menopause symptoms but can be prescribed by a specialist, usually as a gel, typically for postmenopausal women with low libido when HRT alone hasn't helped.

What testosterone can do

For postmenopausal women with HSDD, the 2019 global consensus statement found that testosterone at doses that mimic premenopausal levels improved sexual function: desire, arousal, orgasm, pleasure and responsiveness went up, and sexual distress went down. In practical terms, that worked out to about one more satisfying sexual event per month than placebo. Meaningful for some women, but not a switch that flips your old libido back on.

One caveat: most of the trials included women who were also taking estrogen, so results may not apply as neatly to women who aren't.

What it can't do (based on current evidence)

  • Mood and wellbeing. The consensus statement found no benefit for general wellbeing or depressed mood.
  • Memory, energy and muscles. The meta-analysis behind the statement found no cognitive, psychological or musculoskeletal benefit, including for bone density.
  • Before menopause. The statement says there's not enough data to make any recommendation for premenopausal women.

So if a clinic is selling testosterone mainly for energy, brain fog or "hormone balance," that's ahead of the evidence.

How it's used and monitored

QuestionWhat the 2019 consensus says
Who is it for?Postmenopausal women with HSDD after a full biopsychosocial assessment
Can a blood test diagnose low libido?No. A testosterone level should not be used to diagnose HSDD
What dose?Doses that approximate premenopausal levels
Which route?Non-oral. Oral testosterone is not recommended because of effects on cholesterol
Blood tests?Baseline, again 3 to 6 weeks after starting, then about every 6 months to check for excess
How long to try?If no benefit by 6 months, stop
Compounded products?Not recommended
Men's products?Reasonable when no women's product is approved, if levels stay in the female range

Side effects and unknowns

At female-range doses, the consensus statement says testosterone is linked to mild increases in acne and body or facial hair in some women, but not to hair loss, clitoral enlargement or voice change. Mayo Clinic also mentions mood or personality changes. The bigger issue is what we don't know:

  • Safety data don't extend beyond 24 months of use.
  • Testosterone didn't increase breast density, and short-term use through the skin didn't affect breast cancer risk, but long-term data are lacking. Women with a history of breast cancer were excluded from trials, and caution is advised with hormone-sensitive breast cancer.
  • Non-oral testosterone hasn't shown short-term harm to cholesterol, blood pressure or blood sugar, but women at high heart risk weren't studied.

Before testosterone: check the other causes

Low desire in midlife usually has more than one cause, and a good clinician will look at all of them. Mayo Clinic highlights several:

  • Vaginal dryness and painful sex. GSM can make sex uncomfortable, and that alone can sink desire. Low-dose vaginal estrogen or a vaginal DHEA insert can help, though estrogen won't fix interest and arousal issues on its own.
  • Medications. Some antidepressants, like SSRIs, can lower sex drive.
  • Relationship and stress. Sex therapy or counseling is a first-line approach.
  • Sleep, night sweats and mood. Treating these can make room for desire to return. See the full symptom list for the bigger picture.

Two medicines approved for low desire in the US, flibanserin and bremelanotide, are approved only for women who haven't reached menopause.

When to call your clinician

  • Acne or unwanted hair growth that's bothering you.
  • Changes the consensus says shouldn't happen at female-range doses, such as a deeper voice, hair loss or clitoral enlargement.
  • Mood or personality changes.
  • No improvement after 6 months.
  • A new breast lump or change.

Questions to ask your clinician

  1. Could something else be driving my low desire, like vaginal dryness, my medications, sleep or mood?
  2. Do my symptoms meet the definition of HSDD?
  3. Since no product is approved for women in the US, which product would you use and at what dose?
  4. How often will you check my blood levels?
  5. How will we decide whether it's working, and when would we stop?
  6. Does my personal or family history (breast cancer, heart disease) change the picture?

Sex can be hard to bring up in a short visit. Our doctor visit playbook helps you raise it clearly and get taken seriously.

Questions

Does testosterone help low libido after menopause?

For postmenopausal women with low desire that causes distress (HSDD), yes, modestly. The 2019 global consensus found improvements in desire, arousal, orgasm and pleasure, about one extra satisfying sexual event per month compared with placebo.

Is testosterone FDA-approved for women?

No. As of October 2026 there is no FDA-approved testosterone product for women in the US, so it is prescribed off-label. The FDA held a public meeting on testosterone in menopausal women in September 2026.

Can a blood test show if I need testosterone?

No. The global consensus says a testosterone level should not be used to diagnose low desire. Levels are checked before and during treatment to avoid giving too much.

What are the side effects of testosterone for women?

At female-range doses, mild increases in acne and body or facial hair in some women. Mayo Clinic also lists mood or personality changes. Safety data don't extend beyond 24 months.

Does testosterone help energy, mood or brain fog?

The evidence says no. The consensus statement found no benefit for wellbeing, mood, cognition or bone and muscle, and its only evidence-based use is low sexual desire after menopause.

Founding edition

Get the whole picture in one place

The Sisu Season Guide: every symptom decoded, every option explained, and exactly what to say at your appointment. Instant download. $27 until November 15, $37 after. 30-day money-back guarantee.

Keep reading

Education and personal experience, not medical advice. Talk with your own clinician before making health decisions.

Honest notes on midlife, every Tuesday.

One email a week from Maija: what's happening, what the research says, and how to get heard. Unsubscribe any time.

We never share your email. Your Snapshot answers never leave your device.